• Multiple Myeloma
• Myelodysplastic Syndromes

Dr. Cole then became an attending hematologist at Gundersen Health System in La Crosse, Wisconsin for 9 years. While in Wisconsin, he expanded his research interest to include multiple myeloma, non-Hodgkin’s lymphoma, therapeutic apheresis, and myelodysplasia; participating as the onsite primary investigator for over 21 clinical trials. He then returned to Michigan State University-Karmanos Cancer Institute to continue his focus in hematology and myeloma as the Director of Clinical Cancer Research. He is a member of the American Society of Hematology, International Myeloma Society, and International Myeloma Working Group. Dr. Cole has worked extensively with patient advocacy groups to empower, educate, and bring equitable care to everyone.